Did you know that breast cancer is the leading cause of cancer incidence and mortality among U.S. Latinas? Alarmingly, Hispanic women are 20 percent more likely to die from breast cancer when compared to non-Hispanic white women when diagnosed at a similar age and stage. In response, Susan G. Komen for the Cure is launching Lazos que Perduran, a national, culturally relevant, educational initiative that empowers Latinas with the knowledge and resources to take action. Targeting young adults, the Lazos initiative will promote our breast self awareness messages (know your risk, get screened, know what is normal for you and make healthy lifestyle choices) and motivate them to influence their loved ones to do the same. Telenovela actress Angelica Maria, and her daughter, ...
Dr. Amelie Ramirez, director of Salud America! and the Institute for Health Promotion Research (IHPR) at the UT Health Science Center at San Antonio, was recently named a "Champion of Change” by the President Barack Obama's White House for her contributions to ending suffering from breast cancer. Now Dr. Ramirez has written a blog post for the White House. The inspirational post, "Giving Latinas a Chance Against Breast Cancer," highlights Latinas' cancer issues and discusses ways to overcome barriers:
Prevention is the key, and timely screening, diagnosis, treatment, and follow-up care are critical if Latinas are to survive cancer and sustain a good quality of life.
That’s why my Institute for Health Promotion Research at The University of Texas Health Science Center at San ...
Depression, in addition to other barriers, may prevent Latina breast cancer survivors from undergoing preventive health screening for colorectal and ovarian cancer, according to a new study. The study was presented by Dr. Amelie G. Ramirez, professor and director of the Institute for Health Promotion Research at the UT Health Science Center at San Antonio, on Sept. 19, 2011, at the Fourth AACR Conference on The Science of Cancer Health Disparities in Washington D.C. “Depression can make people more inattentive to potential risks to their health and more likely to ignore recommendations to reduce their risk,” Dr. Ramirez said. Because depression is more common among breast cancer patients than the general population and because 10% of all new cancers are diagnosed in cancer ...
Dr. Deborah Parra-Medina, a professor at the Institute for Health Promotion Research at The UT Health Science Center at San Antonio, is leading a new project to teach Latina moms and daughters in South Texas about the HPV and cervical cancer, which disproportionately affects Latinas. Conexión, a publication of the San Antonio Express-News, has more:
A new program called Entre Mujeres from the Cancer Therapy & Research Center at the UT Health Science center will allow mothers and daughters, ages 11-17, in the lower Rio Grande Valley to come together in a unique setting to educate themselves on HPV and its prevention.
Entre Mujeres will combine community health workers, or “promotoras,” and college students from UT Pan American's Kappa Delta Chi sorority to present educational ...
Check out the latest in health disparities—from San Antonio's push to curb Latino childhood obesity to all aspects of the Latino population boom—in the latest E-newsletter from the Institute for Health Promotion Research (IHPR) at The University of Texas Health Science Center at San Antonio. View the IHPR E-newsletter to see: Story: “BFF” Helps Latina Girl Scouts Get Physically Active (Pg 1)
Story: Targeting Moms, Daughters to Encourage Use of HPV Vaccine on Border (Pg 3)
Story and Video: Latest in Latino Cancer Survivorship (Pg 5)
Story: San Antonio’s Big Push to Thwart Latino Child Obesity (Pg 6)
Story: Latino Population Boom: What Does it Mean? (Pg 7) Find much more on local and national health disparities-related news, funding, resources and events by ...
One of the more aggressive types is triple negative breast cancer, which is diagnosed most frequently in young women and new mothers, and even more so among black and Hispanic women. Now, two North Texas doctors are making major strides in treating triple negative breast cancer. Their work is so promising, the New England Journal of Medicine is publishing a study about the investigational treatment this month, WFAA-TV reports. Research from the doctors show a drug called iniparib, also called BDI-201, has prolonged the lives of more than 50 percent of the patients who have used the treatment. Watch the entire WFAA-TV news segment here or ...
Latinas, here's a reminder to get yourself a holiday gift that can save your life—your annual mammogram, which can detect breast cancer early, when it's most treatable. Watch a true-to-life public service announcement here or below to see why, despite busy lives and a bustling holiday season, Latinas ages 40 and older should set aside time to take care of their own health and get their mammogram: This PSA is brought to you by Redes En Acción, the national Lation cancer research network, which is funded by the National Cancer Institute (NCI) and based at the Institute for Health Promotion Research at The UT Health Science Center at San Antonio. Please tell us what you ...
"Fatalism," a belief that life's events are predetermined, may be one reason why Latinas have some of the lowest cancer screening rates in the U.S., new research suggests. Hispanic women are much more likely than white women to believe that cancer is not preventable, and that death is inevitable in those diagnosed with cancer, the researchers found in the study, scheduled for publication in the online edition of the International Journal of Behavioral Medicine. Researchers identified a statistically significant link between fatalism and reduced use of cancer screening services. Further studies are needed to learn more about this association, the authors noted. "Improving our understanding of the importance of fatalism in explaining underutilization of cancer screening services among ...
White women with private insurance waited an average of 15.9 days between breast cancer testing and confirmatory diagnosis, while privately insured black women waited 27.1 days and Latinas 51.4 days, according to a new study. The study, which involved almost 1,000 women examined for breast cancer, indicates that race/ethnicity plays a larger role than insurance in getting a timely breast cancer diagnosis. For women on Medicare or Medicaid, the wait between testing and diagnosis was 11.9 days for whites, 39.4 days for blacks and 70.8 days for Latinas. Among those without insurance, the wait was 44.5 days for whites compared with 59.7 days for blacks and 66.5 days for ...
